| Literature DB >> 20453839 |
Amy L Sherborne1, Fay J Hosking, Rashmi B Prasad, Rajiv Kumar, Rolf Koehler, Jayaram Vijayakrishnan, Elli Papaemmanuil, Claus R Bartram, Martin Stanulla, Martin Schrappe, Andreas Gast, Sara E Dobbins, Yussanne Ma, Eamonn Sheridan, Malcolm Taylor, Sally E Kinsey, Tracey Lightfoot, Eve Roman, Julie A E Irving, James M Allan, Anthony V Moorman, Christine J Harrison, Ian P Tomlinson, Sue Richards, Martin Zimmermann, Csaba Szalai, Agnes F Semsei, Daniel J Erdelyi, Maja Krajinovic, Daniel Sinnett, Jasmine Healy, Anna Gonzalez Neira, Norihiko Kawamata, Seishi Ogawa, H Phillip Koeffler, Kari Hemminki, Mel Greaves, Richard S Houlston.
Abstract
Using data from a genome-wide association study of 907 individuals with childhood acute lymphoblastic leukemia (cases) and 2,398 controls and with validation in samples totaling 2,386 cases and 2,419 controls, we have shown that common variation at 9p21.3 (rs3731217, intron 1 of CDKN2A) influences acute lymphoblastic leukemia risk (odds ratio = 0.71, P = 3.01 x 10(-11)), irrespective of cell lineage.Entities:
Mesh:
Year: 2010 PMID: 20453839 PMCID: PMC3434228 DOI: 10.1038/ng.585
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 38.330